Ultraviolet (UV) light exposure is a common cause of epithelial-derived skin cancers, and the epidermal response to UV-light has been extensively studied using both mouse models and cultured human keratinocytes (KCs). Elimination of cells with UV-induced DNA damage via apoptosis provides a powerful mechanism to minimize retention or expansion of genetically abnormal cells. This cell editing function has largely been ascribed to the biological role of the p53 tumor suppressor gene, as mutations or deletions involving p53 have been linked to skin cancer development. Rather than introducing mutations, or using cells with complete loss of wild-type p53, we used an siRNA-based approach to knockdown, but not eliminate, p53 levels in primary cultures of human KCs followed by UV-irradiation. Surprisingly, when p53 levels were reduced by 50-80% the apoptosis induced by exposure to UV-light was accelerated and markedly enhanced (two-to three-fold) compared to control siRNA treated KCs. The p53 siRNA treated KCs were characterized by elevated E2F-1 levels accompanied by accelerated elimination of the Mcl-1 and Bcl-x L antiapoptotic proteins, as well as enhanced Bax oligomerization. Forced overexpression of either Mcl-1 or Bcl-x L reduced the UV-light enhanced apoptotic response in p53 siRNA treated KCs. We conclude that p53 not only can provide proapoptotic signals but also regulates a survival pathway influencing Mcl-1 and Bcl-x L levels. This overlooked survival function of p53 may explain previous paradoxical responses noted by investigators using p53 heterozygous and knockout mouse models, and opens up the possibility that not all liaisons within the cell involving p53 necessarily represent fatal attractions.
Introduction
When epidermal keratinocytes (KCs) are exposed to ultraviolet (UV)-light, they can either become growth arrested, prematurely senesce, or undergo apoptosis (Chaturvedi et al., 1999; Qin et al., 2002) . The apoptotic response has been extensively studied because elimination of DNA damaged KCs is an efficient and powerful protective mechanism for preventing development of skin cancer (Ziegler et al., 1994) . While UV-light exposure triggers an assortment of cellular alterations involving multiple signaling pathways, dissection of the apoptotic response revealed it is principally mediated by mitochondrial dysfunction (Jackson et al., 2000; Nickoloff et al., 2002; Bowden, 2004) .
Of all the signaling molecules impacted by UV-light exposure, perhaps most well studied is the tumor suppressor, p53. There are many reasons to link abnormalities in p53 signaling with development of UV-light responses, with an obvious relationship to skin cancer. First, it was demonstrated early on that precancerous human skin lesions, and later invasive skin cancers, frequently harbored p53 mutations bearing UV-light induced mutation signatures (Brash et al., 1991; Nelson et al., 1994; Ouhtit et al., 1998; Bolshakov et al., 2003) . Second, use of p53 null mice, or mice engineered to overexpress mutated p53 proteins, were found to display increased incidences of malignant progression and conversion (Kemp et al., 1993; Weinberg et al., 1994) . Also, murine keratinocyte cultures derived from such mice were observed to have decreased apoptotic responses to UV-light.
However, several paradoxical observations were also made when investigators further pursued a role for p53 in cutaneous carcinogenesis studies (Greenhalgh et al., 1996; Jiang et al., 1999) . When p53 heterozygote mice were studied, there were actually fewer skin cancers following various carcinogenesis protocols, and p53 null mice showed marked resistance to tumor formation when crossed with epidermal targeted oncogene-expressing mice (Greenhalgh et al., 1996; Jiang et al., 1999) . Since one of the key differences between the expected and the unexpected in vivo results involved the relative levels of wild-type p53, we decided to explore the effect of only reducing, but not eliminating, wild-type p53 levels in cultured human KCs before and after UV-irradiation.
Another relevant point to consider is that most cancer-associated growth-promoting signals are directly coupled to increased cell death (Hanahan and Weinberg, 2000) . Thus, if proto-oncogenes such as c-myc are activated, then hyperproliferative cells with sustained E2F-1 levels are more susceptible to apoptosis (Evan et al., 1992; Wang et al., 2004) . In this report, we focus on reduction of a tumor suppressor gene (i.e. p53), and extend this paradigm involving dysregulation of E2F-1, with apoptotic vulnerability, by also demonstrating enhanced apoptotic signaling in human KCs.
Returning to the proapoptotic function of p53, initial studies focused on the transcriptional regulatory functions (Levine, 1997) , but more recent investigations have uncovered transcription-independent activities (Perfettini et al., 2004) . Of particular note, p53 appears to directly impact the function of mitochondria -which puts p53 at the same intracellular location as the site of UV-light induced apoptotic reactions (Vousden, 2000) . These multifaceted roles for p53 have complicated interpretation of results, and sometimes produced erroneous conclusions (Sherr, 2004) . When p53 was first discovered, it was labeled as a proto-oncogene, and only later was it correctly identified as a tumor suppressor (Finlay et al., 1989) . Initial emphasis was placed on the ability of p53 to mediate apoptosis by transcriptionally activating various proapoptotic genes such as Bax and death receptors (Vousden, 2000; Fridman and Lowe, 2003) . However, a few reports appeared that suggested p53 may also regulate survival pathways (Hawkins et al., 1996; Wahl et al., 1996; McKay et al., 2000) . The most recent reports have returned to the proapoptotic role for p53 by localizing it to the mitochondria (Perfettini et al., 2004) , and interacting with various proteins that can impact life and death decisions within the cell such as Bcl-2, Bcl-x L , Bax, Bak and Mcl-1 (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004) . Thus, there are proteins which subserve an antiapoptotic function in KCs such as Bclx L and Mcl-1, whereas other proteins promote apoptosis such as Bax and Bak (Mihara et al., 2003; Chipuk et al., 2004; Leu et al., 2004) . The ultimate fate for KCs as regards survival or cell death following UV-light exposure is dependent on the relative levels of proapoptotic vs antiapoptotic factors . The balance of these proteins regulates the mitochondrial integrity; and release of apoptotic proteins from the mitochondria that ultimately produce cell death (Martinou and Green, 2001) .
The potential role for the survival protein Mcl-1 is of particular interest to investigative skin biologists because Nijhawan et al. (2003) have demonstrated that elimination of Mcl-1 is required for initiation of apoptosis following UV-light exposure. Indeed, we have observed that levels of Mcl-1 mRNA rapidly decrease in human KCs even following relatively low doses of UVlight irradiation (Qin et al., 2004) . Studies of the transcriptional and translational control of Mcl-1 during apoptosis revealed that this Bcl-2 family member is characterized by a short half-life at the mRNA and protein level (Iglesias-Serret et al., 2003) . Factors that upregulate Mcl-1 levels include phorbol ester, IFNalpha, and growth factors such as IL-3, IL-6 and GM-CSF (Jourdan et al., 2003) . The depletion of Mcl-1 has been linked to both caspase-dependent and caspaseindependent mechanisms (Iglesias-Serret et al., 2003) . It has also been established that E2F-1 can directly repress the Mcl-1 promoter (Croxton et al., 2002) .
Based on a large number of results focusing on the proapoptotic and cell editing function of p53 (Ziegler et al., 1994; Levine, 1997; Vousden, 2000; Fridman and Lowe, 2003) , it would be expected that reducing p53 levels should lower the apoptotic response of cells. Instead, we observed elevated apoptosis using UV-light irradiated KCs in which p53 levels were knocked down by siRNA pretreatment. An siRNA-based approach was utilized because of prior success in other mammalian cells (Brummelkamp et al., 2002) . Moreover, this enhanced apoptotic response was significantly reduced when the accelerated elimination of Mcl-1 or Bcl-x L was prevented by the forced overexpression of either Mcl-1 or Bcl-x L . Thus, we conclude that p53 levels regulate survival pathways in human KCs, which involve modulation of antiapoptotic proteins such as Mcl-1 and Bcl-x L that facilitate enhanced Bax oligomerization and cell death. Taken together, these results highlight complex mechanisms regulating life or death responses involving p53. Such new insights may contribute to therapeutic strategies targeting p53 responses in epithelial cell-derived neoplasms that may also impact normal KCs (Vousden and Lu, 2002) .
Results

p53 siRNA reduces protein level and p53-dependent transcriptional activity in KCs
Exposure of proliferating human primary KCs to a pooled collection of p53 siRNAs (hereafter referred to as p53 siRNA) led to morphological changes in the KCs. When KCs were exposed to p53 siRNA they appeared by phase contrast microscopy to be smaller, more basaloid and refractile appearing upon reaching confluency compared to KCs exposed to control siRNA ( Figure 1a ). Harvesting protein from such confluent cultures revealed a markedly diminished level (6.4-fold reduction) of p53 in p53 siRNA treated KCs relative to control siRNA treated KCs (Figure 1b) . Reporter assays confirmed the Western blot analysis with two different p53-dependent promoters (i.e. p21 and GADD45) displaying reduced luciferase activity in p53 siRNA treated KCs relative to control KC cultures (Figure 1c, d, respectively) .
p53 silencing influences cell cycle and apoptotic regulatory proteins accompanied by enhanced replicative potential of KCs
To assess the impact of p53 siRNA exposure on proteins that govern proliferation and survival, whole-cell extracts were collected from either proliferating or confluent KC cultures grown in the presence or absence Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al of p53 siRNA (Figure 2a ). Immunoblot analysis revealed a consistent reduction in p53 levels in the p53 siRNA treated KCs in both proliferating as well as confluent KC cultures. Given extensive cross-talk between p53 and RB pathways, the initial focus was centered on relative levels of cyclin-dependent kinase inhibitors such as p21 and a p53 family member p63, as well as the activation status of RB (Tsai and Tsao, 2004) . In both proliferating and confluent KC cultures, the p53 siRNA treated KCs were characterized by reduced p21 levels (with greater reduction observed in confluent KC cultures), whereas p63 levels were slightly elevated in the confluent KC cultures (Figure 2a, b) . In proliferating KCs (either control or p53 siRNA treated), RB was present predominantly in the hyperphosphorylated or inactive configuration. However, at confluency the p53 siRNA treated KCs were characterized by the presence of both inactive and active forms of RB, compared to control siRNA treated KCs in which RB was only detected in the active (hyperphosphorylated) configuration. Given differences in the status of RB, there were also increased levels of E2F-1 in p53 siRNA treated KCs (both proliferating and confluent) compared to control siRNA treated KCs. Moving to proteins that directly regulate cell survival, the high constitutive levels detected for Bcl-x L and Mcl-1 in proliferating and confluent control siRNA treated KCs contrasted to their reduced levels in p53 siRNA treated KCs (both proliferating and confluent cultures). The proapoptotic protein, Bax, was constitutively present in proliferating and confluent control siRNA treated cultures, but was reduced in p53 siRNA treated cultures. Id-1 was detectable in proliferating control siRNA treated KCs, which was reduced upon confluency; whereas enhanced Id-1 levels were present in p53 siRNA treated KCs. Since p53, p63, and Id-1 can regulate the replicative potential of KCs (Alani et al., 1999; Nickoloff et al., 2000; Campisi, 2004; Honeycutt et al., 2004) , the ability of KCs to proliferate in culture was assessed ( Figure 2c ). When control siRNA treated KCs were allowed to reach confluency, subsequent replating revealed only a limited number of population doublings under these experimental conditions (Figure 2c ). By contrast, even when p53 siRNA KC cultures reached confluency, several additional replatings produced population doublings as reflected in Figure 2c . Thus, reduction in p53 levels in KCs delayed, but did not prevent, the onset of replicative senescence.
Enhanced apoptotic response of confluent p53 siRNA treated KCs
Since p53 siRNA treatment effectively modulated the level of a number of proteins that regulate cell cycle and Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al survival, we analysed the apoptotic response to UVlight. A previous report indicated that confluent KCs were highly resistant to UV-light induced apoptosis (Chaturvedi et al., 1999) , and hence we compared and contrasted the effects of UV-light exposure on confluent KCs treated with either control siRNA or p53 siRNA ( Figure 3 ). While no differences in the spontaneous apoptosis were observed (less than 5% of the population contained KCs with a sub-G 0 DNA content after propidium iodide staining and FACS analysis), exposure to either 15 or 30 mJ/cm 2 triggered significantly higher levels of apoptosis in p53 siRNA treated KCs after 24 h (Figure 3a ). Not only was the extent of apoptosis increased, but the induction of apoptosis was accelerated in siRNA treated KCs following UV-light exposure (30 mJ/cm 2 ) at the 6 and 18 h time points (Figure 3b , c). The morphological appearance of confluent KC cultures 6 and 18 h following UV-light exposure (30 mJ/cm 2 ) revealed rare KCs displaying membrane blebbing and detachment from the monolayer at either 6 or 18 h, but numerous KCs undergoing apoptosis were already visible at 6, and by 18 h the majority of KCs displayed typical apoptotic morphology ( Figure 3c ). To confirm apoptosis, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining was performed and revealed scattered positive cells within the p53 siRNA treated KCs exposed to UV-light for 6 h compared to the control siRNA treated KCs (Figure 3c inset). Cultures stained for TUNEL were negative in the absence of UVlight exposure for both control siRNA and p53 siRNA treated KCs (data not shown). Exposure of KCs to p53 siRNA modulates numerous protein levels impacting the regulation of cell cycle and apoptotic pathways; as well as influencing the replicative potential of cultured KCs. (a) p53 siRNA treatment significantly changes the constitutive levels for several proteins in both proliferating as well as confluent KCs. The composite Western blot analysis reveals reduced levels in p53 siRNA treated KCs for p53, p21, Bax, Bcl-x L , and Mcl-1, whereas enhanced levels were observed for p63 and E2F-1. At confluency, the p53 siRNA treated KCs contained an inactive isoform (hyperphosphorylated, ppRB) of RB. Actin levels confirm equivalent findings. Results are representative of three independent experiments. (b) Quantitative analysis of relative protein levels comparing siRNA treated KCs to control siRNA treated KCs in proliferating (white bars) as well as confluent (gray bars) cultures as depicted in (a). The data was quantified by densitometry analysis as described in Materials and methods. (c) Reduction in p53 levels using p53 siRNA enhanced the replicative potential of KCs compared to control siRNA treated KC cultures. KCs were grown in low calcium, serum-free medium using standard conditions as described in Materials and methods. Note that upon reaching confluency, control siRNA treated KCs underwent limited population doublings, whereas the p53 siRNA treated KCs continued to divide for several additional population doublings prior to undergoing replicative senescence. Results portrayed are representative of two independent cultures Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al
Regulation of mRNA levels in KCs before and after UVlight exposure
Given changes in constitutive protein levels for key survival and proapoptotic factors observed for p53 siRNA treated KCs vs control siRNA treated KCs (Figure 2a ), as well as the enhanced and accelerated apoptotic response of p53 siRNA treated KCs to UV-light ( Figure 3a , b), we examined the relative mRNA levels of apoptosis-related genes before and after UV-light. Using RNase protection assay (RPA), p53 siRNA treated KCs had lower constitutive mRNA levels for p53, Bcl-x L , c-Fos, and Bax ( Figure  4a , b). At both 3 and 6 h following UV-light exposure (30 mJ/cm 2 ) the p53 siRNA treated KCs were characterized by lower mRNA levels for p53, Bcl-x L , p21, Bax, and Mcl-1 relative to control cultures (Figure 4a , b).
Accelerated loss of Mcl-1 accompanied by enhanced mitochondrial cytochrome c release and Bax oligomerization in p53 siRNA treated KCs
Since Mcl-1 is a key survival protein that protects KCs against UV-light induced apoptosis (Nijhawan et al., 2003) , the relative Mcl-1 protein levels were examined before or immediately following UV-light exposure (30 mJ/cm 2 ). While constitutive Mcl-1 levels were comparable between control siRNA treated KCs and p53 siRNA treated KCs, a significantly reduced level for Mcl-1 was present at 6 h in the p53 siRNA treated KCs (Figure 5a ). At 18 h after UV-light exposure both control and p53 siRNA treated KCs eliminated almost all of the Mcl-1 as detectable by immunoblot analysis (Figure 5a ).
To evaluate mitochondrial membrane permeability, both cytosolic and mitochondrial-enriched functions were isolated, and the levels of cytochrome c and Smac-1 assessed by immunoblot analysis. In both unirradiated control siRNA and p53 siRNA treated KC cultures, all cytochrome c was present only in the mitochondrial fraction, with no detectable levels in the cytoplasm (Figure 5b ). At 6 h after UV-light exposure (30 mJ/cm 2 ), the p53 siRNA treated KC cultures were characterized by loss from cytochrome c for the mitochondrial fraction, and presence in the cytosol. There was no detectible cytochrome c in the cytosol of control siRNA treated KCs after 6 h of UV-light exposure (Figure 5b ). Smac-1 was also preferentially released by the mitochondria and detected in the cytosol only in the UVlight exposed p53 siRNA treated KCs ( Figure 5b ).
As cytochrome c release for the mitochondria is regulated by Bax oligomerization (Mikhailov et al., 2003) , the detection of Bax monomers and dimers was assessed before and after UV-light exposure (30 mJ/ . No Bax dimers were present in unirradiated KC cultures, but Bax dimers were detected as early as 6 h, following UV-light exposure in p53 siRNA treated KC cultures (Figure 5c ). At 18 h, Bax dimers were present in both control and p53 siRNA treated KCs.
Reversal of enhanced apoptotic susceptibility in p53 siRNA treated KCs by forced overexpression of Mcl-1 or Bcl-x L To establish a direct cause : effect relationship between the accelerated loss of Mcl-1 and Bcl-x L with the enhanced apoptotic vulnerability in p53 siRNA treated KCs exposed to UV-light, the KC cultures were examined after the cells had been infected with retroviral constructs to force overexpression of these key survival proteins. Verification of enhanced Mcl-1 and Bcl-x L levels in the retroviral infected KCs was accomplished using immunoblots (Figure 6a ). The loss of Mcl-1 18 h after UV-light exposure (30 mJ/cm 2 ) in both control and p53 siRNA treated KCs was clearly compensated for by the use of the retroviral constructs as enhanced constitutive and sustained Mcl-1 levels after UV-light exposure were detected in both control and p53 siRNA treated KC cultures (Figure 6a, right side) . Similarly, the lower constitutive Bcl-x L levels in p53 siRNA treated KCs and reduced Bcl-x L levels following UV-light (30 mJ/cm 2 ) in both control and p53 siRNA treated KCs was compensated for by the use of the Bcl-x L containing retroviral construct (Figure 6a , right side).
Having confirmed the enhanced protein levels for either Mcl-1 or Bcl-x L in the KC cultures, that apoptotic response to UV-light (30 mJ/cm 2 ) was assessed. By overexpressing Mcl-1 or Bcl-x L , the apoptotic response following UV-light exposure was significantly reduced in both control siRNA treated KCs as well as p53 siRNA treated KCs (Figure 6b ).
Forced overexpression of E2F-1 levels in KCs enhances spontaneous and UV-light induced apoptosis, which is reversed by Mcl-1 overexpression Since E2F-1 levels were enhanced in p53 siRNA treated KCs relative to control siRNA levels (Figure 2a) , and because E2F-1 levels are known to influence apoptotic susceptibility in various cell types (Dick and Dyson, 2003; Knezevic and Brash, 2004) , normal KCs were infected with a retroviral construct to force overexpression of E2F-1 and the spontaneous and UV-light induced apoptotic responses were determined. In addition, KC cultures were also infected with a retroviral construct to force overexpression of Mcl-1 either alone or in combination with E2F-1. Confirmation of enhanced expression for both E2F-1 and Mcl-1 before, and after, UV-light exposure (30 mJ/cm 2 , 6 h) was accomplished using immunoblot analysis (Figure 7a) .
When KCs were infected with an E2F-1 containing retroviral construct, there was an increased spontaneous apoptotic response with approximately 12% of the population undergoing apoptosis compared to less than Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al p53 wild-type mice after 24 h (Ziegler et al., 1994) . Given the accelerated induction of apoptosis in p53 siRNA treated human KCs, we explored the in vivo apoptotic response of p53 þ /À mice compared to p53 þ / þ mice at 6 h. Using an antibody to detect activated caspase 3 positive KCs, the skin of UV-irradiated mice was assessed for KCs undergoing apoptosis (Figure 8a-c) . The number of activated caspase 3 positive KCs was significantly reduced in the p53 þ /À mice compared to the p53 þ / þ mice.
Discussion
The precise cellular and molecular events contributing to development of UV-light induced skin cancer is a complex, multistep process that is incompletely understood (Leffell and Brash, 1996) . In this study, a survival role for p53 was uncovered in the UV-light response of cultured human epidermal-derived KCs. While the proapoptotic role for p53 has been well documented in a number of cell types both in vitro and in vivo, this is the first data set to delineate a previously unknown antiapoptotic role for p53 in normal KCs. Downregulation, but not elimination, of p53 in KCs led to an accelerated and more extensive cell death response following exposure to UV-light. Furthermore, the reduction in p53 levels enhanced the replicative potential of KCs. Thus, p53 not only can influence the survival function of KCs but also p53 levels impact the onset of replicative senescence in human KCs. A pictorial summary of the effects of lowering p53 levels in human KCs on the proliferative potential and apoptotic responsiveness is portrayed in Figure 8d . These results are consistent with transgenic mice engineered to constitutively activate p53 producing an early senescence-associated phenotype that was particularly evident in the skin (Tyner et al., 2002) .
While analysis of p53-regulated global profiling emphasizes the complexity in defining the type, strength, and kinetics of target gene expression (Zhao et al., 2000) , we identified at least two key survival proteins (e.g. Mcl-1 and Bcl-x L ) that are critically important in mediating the accelerated and enhanced apoptotic response to UV-light in p53 siRNA treated KCs. By reversing the premature loss or decline in these two proteins using appropriate retroviral constructs, the apoptotic response to UV-light was significantly reduced. These studies provide a mechanistic basis for survival pathways regulated by p53, and open a new line of inquiry toward a more thorough understanding of the complex roles for p53 in skin biology, and response of KCs to DNA damaging agents such as UV-light. The overexpression of Mcl-1 or Bcl-x L was confirmed by immunoblotting as described in Materials and methods. The retroviral infected KCs were stimulated with UVlight and protein extracts were collected before and after irradiation, and parallel dishes were also stained with PI to assess DNA content using flow cytometry as described in Materials and methods. By Western blot analysis, the accelerated decline in Mcl-1 levels previously documented in irradiated p53 siRNA treated KCs (Figure 5a An siRNA-based knockdown of p53 levels was utilized to mimic the clinical situation in which UVlight would be expected to function in a multistep model with initial loss of one allele by introducing signature mutations giving rise to KC populations within the exposed epidermis for a period of time prior to an additional mutagenic event affecting the second allele. Thus, rather than comparing the KC response of wildtype p53 to cells with loss of function of both alleles (p53 null), we created KC cultures with cells that had retained detectable levels of p53, albeit at 70-80% reduction. Since this exceeds a 50% reduction, this siRNA approach may not completely reflect the in vivo clinical situation, but such an experimental approach did lead to completely unexpected results in which specific survival pathways regulated by p53 emerged using cultured human KCs.
The current results in which p53 siRNA treated KCs possessed greater UV-light induced apoptosis is consistent with an earlier report using immortalized KCs (e.g. HaCaT cells) (Chaturvedi et al., 2001) . HaCaT cells were derived from human KCs and are characterized by inactivitating mutations in both p53 alleles. Rather than being relatively resistant to UV-light induced apoptosis, these cells were highly susceptible to UV-light induced apoptosis, which was also associated with elevated E2F-1 levels. Using human fibroblasts and colon cancer cell lines, and a temperature switching induction system for regulating wild-type p53 levels, another group has identified a protective The impact of UV-light on the self-renewing epidermal KC population is very complex and includes: DNA damage, growth arrest, senescence, and apoptosis (i.e. formation of sunburn cells). Since the p53 gene encodes a protein that can both bind DNA and influence cell cycle and apoptotic pathways, as well as a protein that can directly impact the mitochondria (Perfettini et al., 2004) and also modulate cell survival, it is not surprising that considerable attention has been devoted to elucidating a key role for p53 in carcinogenesis. UVB-light can produce thymine dimers and/or CT transition (socalled UV-molecular signature) in the p53 gene. In chronically sun-damaged human skin, p53 mutations are present at increased frequency, and in experimental animals, UV-light induced p53 mutations occur early in the mouse epidermal KCs prior to tumor formation (Nakazawa et al., 1994; Ananthaswamy et al., 1997) . However, a clinical study involving patients with LiFraumeni syndrome, in which patients inherit a mutation in one allele of p53, revealed that these individuals did not possess an increased frequency of sun-induced squamous cell carcinoma (Malkin et al., 1990) . This observation provided an early cautionary signal against a simple relationship between p53 and skin cancer, and ushered in a wave of investigations using transgenic mice attempting to unravel the mystery of p53 in cutaneous carcinogenesis.
Using p53 null mice, it became clear that mice exposed to either chemical carcinogenesis or UV-light induced carcinogenesis protocols were characterized by dramatically increased susceptibility to skin cancer induction and progression as reported by many independent investigators. Moreover, p53 null mice exhibited markedly reduced UV-light induced apoptotic responses in epidermal KCs compared to wild-type mice, and the p53 þ /À (heterozygous) mice displayed an intermediate apoptotic response between p53À/À and p53 þ / þ mice. While there was a remarkable consensus among investigators, and no surprises using p53 null vs wild-type mice in supporting the hypothesis that p53 regulated cancer development in the skin by promoting apoptosis of KCs bearing p53 mutations, many paradoxical observations and divergent results emerged by investigators studying partial, rather than complete, loss of p53.
In 1993, Kemp et al. (1993) employed a chemical carcinogenesis protocol in p53 heterozygous mice and concluded that a reduction (but not elimination) of p53 gene dosage did not increase initiation or promotion of skin cancer, although it did enhance progression of those tumors that developed. This tumor progression was associated with loss of the remaining wild-type allele. Greenhalgh et al. (1996) reported another set of paradoxical results in which p53 reduction conferred a tumor block using a two-stage mouse skin chemical carcinogenesis protocol. Perhaps of greatest relevance to the current results, Kripke et al. reported on the incidence of squamous cell carcinomas using a UV-light based protocol in congenic mice that differed only in the Figure 8 Irradiation of the skin of p53 heterozygous (p53 þ /À) transgenic mice reveals reduced KC apoptosis compared to wildtype (p53 þ / þ ) mice. (a) Microscopic appearance of p53 wt transgenic mouse skin 6 h after UV-light exposure (100 mJ/cm 2 ) immunostained to detect apoptotic KCs expressing activated caspase 3. Note the frequent number of basal layer KCs (identified by vertical arrows) containing activated caspase 3 as detected by bright red cytoplasmic immunoreactivity. The mice were irradiated and the skin processed as described in Materials and methods. Immunostained sections with 3-aminoethylcarbazole serving as the chromogen producing a positive red reaction product. Magnification Â 40. Results portrayed are representative of six different irradiated mice. (b) Microscopic appearance of p53 heterozygous transgenic mouse skin 6 h after UV-light exposure as described in Figure 8a . (c) Quantitative analysis of caspase 3 positive KCs in the epidermis of irradiated skin from p53 wt vs p53 heterozygous mice. The differences between these groups of mice are significant (Po0.01). (d) Summary of relevant pathways impacted by reducing p53 levels in human KCs that contribute to the enhanced apoptotic response to UV-light Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al p53 locus (Jiang et al., 1999) . In this report involving between 24 and 31 different mice, the incidence of squamous cell carcinoma for p53À/À, þ /À, and þ / þ mice were as follows: 37, 9, and 20%, respectively. Thus, while this group confirmed that p53 null mice were almost twice as likely to develop skin cancer following UV-light irradiation, the p53 þ /À mice were actually significantly protected from the UV-light induced squamous cell carcinomas. Taken together, these experimental models clearly highlight the complexity of roles for p53 in epidermal biology and cutaneous carcinogenesis. Moreover, the epidermal KC response to either chemical carcinogenesis or UV-light is highly dependent on the cellular context in which cells express either wild-type p53 on one allele, or two alleles versus a p53 null status. How can new insights gained from the current study impact therapeutic strategies involving UV-induced skin carcinogenesis? While there appears to be a strong impetus to reactivate p53 functions in cancer cells, and such restoration may hold potential, caution is warranted based on the antiapoptotic role for p53 (Foster et al., 1999; Bykov et al., 2002; Friedler et al., 2002) . Indeed, the paradoxical reduction in skin cancers occurring in p53 þ /À transgenic mice may parallel the current experience with human p53 siRNA treated KCs in which enhanced apoptosis following UV-light exposure was observed. However, when we directly examined the apoptotic response of p53 heterozygous transgenic mice, there was no evidence for enhanced apoptotic susceptibility 6 h following high-dose UVlight exposure. Such divergent results highlight fundamental differences in the apoptotic responses of human vs mouse KCs (Chaturvedi et al., 2004) , and further challenge investigators to validate conclusions drawn from mouse models that are frequently extrapolated to human skin without making clinically relevant comparisons. Thus, using p53 null transgenic mice and comparing the incidence or biological behavior of UVinduced tumors to p53 wild-type mice may not necessarily provide results that are relevant to the understanding of mechanisms that regulate conversion of actinic keratoses that may have mutated one p53 allele to invasive squamous cell carcinoma that may have lost both p53 alleles. Of course, it is also important to point out that many p53 mutations in human cancer do not lead to a complete loss of p53 protein; indeed, mutant p53 may accumulate and could potentially participate in unconventional pro-or antiapoptotic pathways.
Another aspect of the UV-light induced response in KCs involves DNA repair mechanisms. The principal pathway for elimination of UV-light induced photo lesions in DNA is nucleotide excision repair, which includes transcription-coupled and global genome repair subpathways (Maeda et al., 2002; van Oosten et al., 2005) . Since p53 has been implicated in regulating the DNA repair (Lee et al., 1995; Reed et al., 1995) , it is possible the enhanced apoptotic vulnerability of p53 siRNA treated KCs reflects a reduced capacity for efficient removal of photo lesions within the irradiated KCs. Further studies are indicated to define the role of p53 regulated genes in the apoptotic response of KCs to UV-light with respect to DNA repair.
Finally, it is worth noting that p53 may also regulate the biology of stem cells by influencing their replicative potential and apoptotic susceptibility (Rambhatla et al., 2001) . Based on our current results using human KCs, an explanation for the paradoxical results observed by multiple investigators in which engineering mice to possess epidermal KCs with enhanced survival by inactivating p53 (Kemp et al., 1993; Greenhalgh et al., 1996; Jiang et al., 1999) , could involve the enhanced susceptibility of epidermal stem cells to UV-light when p53 levels are reduced (Zhang et al., 2005) . Thus, even if adjacent transient amplifying KCs are made resistant to UV-light induced apoptosis, there would still be reduced tumorigenesis because the stem cells bearing UV-light mutations would be more efficiently eliminated when p53 levels are reduced (Tudor et al., 2004) . In conclusion, further studies are indicated to determine the precise role for p53 in human skin as regards proliferative potential and apoptotic susceptibility of epidermal KCs.
Materials and methods
Cell Culture
Primary KCs were isolated from freshly excised neonatal foreskins as described previously (Chaturvedi et al., 1999; Qin et al., 2002) . KCs were maintained in a low calcium (0.15 mM) serum-free KC growth medium (KGM, Clonetics, San Diego, CA, USA) within a 371C humidified incubator containing 5% CO 2 .
siRNA Treatment A pool of p53 siRNAs was purchased from Dharmacon (Denver, CO, USA) SMART Pool cat # M-003557-00-05. A nonspecific control siRNA was used (cat # D-001206-02-05) as recommended by the manufacturer. KCs were seeded at 30% density the day before the transfection. Cells were transfected with OligofectAMINE (Invitrogen, Carlsbad, CA, USA) transfection reagent according to the manufacturer's protocol. Cells were then exposed to UV-light after 72 h of siRNA, and then harvested for protein analysis or for the apoptotic assays.
Replicative capacity and cell proliferation
Proliferation assays were performed to assess the longevity of the KC cultures by calculating population doublings after confluency and reseeding as described (Rheinwald et al., 2002) . In brief, equal numbers of cells were plated and treated with p53 siRNA or control siRNA. KCs were counted upon reaching confluency, and every 7 days following reseeding of the KCs with fresh medium changes every 2-3 days. Population doublings per passage were calculated as log 2 number of cells at time of subculture/number of cells plated, as described (Rheinwald et al., 2002) .
Apoptosis assay
Flow cytometry was performed on single-cell suspensions obtained using trypsin/EDTA as described previously (Chaturvedi Paradoxical enhancement of UV-induced apoptosis V Chaturvedi et al et al., 1999) . Briefly, cells were trypsinized, fixed with ethanol, and stained with propidium iodide (50 mg/ml, Sigma Chemical Co., St Louis, MO, USA) according to the manufacturer's instructions, then analysed on a Coulter Epics XL-MCL flow cytometer. Cells with DNA content less than the G 0 /G 1 amount of untreated cells were considered apoptotic. Detection of cells undergoing apoptosis was also performed using commercially available kit for in situ nick translation and TUNEL, following the manufacturer's instructions (ApopTag Peroxidase InSitu Apoptosis Detection Kit: S7100; Chemicon International, Temecula, CA, USA). Briefly, KCs were grown on eight-well Lab Tek chamber slides, and following UV-light exposure, were fixed and processed using standard procedures.
UV treatment
Apoptosis was induced by irradiating KCs with a Panelite Unit (Ultralite Enterprises, Inc., Lawrenceville, GA, USA) equipped with four UVB bulbs (FS36T12/UVB-VH0) that have the majority of their output in the UVB range (65%), with minor output in the UVA and UVC range (34 and 1%, respectively). KCs were irradiated with dish lids removed using a different dose of UV. The UV dose was monitored with an International Light, Inc. (Newburyport, MA, USA) radiometer fitted with a UVB detector as described previously (Chaturvedi et al., 1999; Qin et al., 2002) . Medium from the cells were removed, rinsed, and replaced with buffer.
Retroviral constructs and infection
Bcl-x L and E2F-1 cDNAs were subcloned into the BamHI and NotI of LZRS-based retroviral expression vector. The Mcl-1 cDNA, kindly provided by Dr W Douglas Cress (University of South Florida College of Medicine), was cloned into the HindIII and XhoI sites of LZRS-Linker. The LZRS vector containing enhanced green fluorescent protein was kindly provided by Dr Paul A Khavari (Stanford University School of Medicine, Stanford, CA, USA). The Phoenix-Ampo retroviral packaging cells were obtained from American Type Culture Collection (Manassas, VA, USA) with permission from Dr Gary P Nolan (Stanford University Medical Center, Stanford, CA, USA). The packaging cells were cultured in Dulbecco's modified Eagle's medium (Life Technologies, Inc., Grand Island, NY, USA) and transfected with LZRS-Mcl-1, Bcl-x L , and E2F-1 vector by using CaCl 2 and 2 Â HBSS. After overnight incubation, the cells were fed with fresh medium and incubated at 321C for an additional 24-48 h. The supernatants were collected for cell infection. KCs were seeded into six-well plates and infected with 300 ml of viral supernatant in the presence of 4 mg/ml hexadimethrine bromide (Polybrene, Sigma H-9268) for 1 h at 321C, then the supernatant was removed and replaced with fresh medium, incubated at 371C in a humidified incubator with 5% CO 2 overnight. After being washed with PBS, the infected cells were propagated and treated with UV-light. Overexpression of the relevant proteins was confirmed by Western blot analysis.
Reporter assay
KCs were seeded at 30% confluency, after 48 h of transfection with p53 siRNA, Fugene6 (Invitrogen) was used to transfect GADD45 or p21 LUC reporter constructs. At 48 h after reporter construct transfection, luciferase assay was performed using the Dual Luciferase Reporter Assay System (Promega, Madison, WI, USA), and measured using a Sirius FB15 luminometer (Zylux Corp., Maryville, TN, USA).
Immunoblot analysis and subcellular fractionation
For whole-cell lysates, KCs were washed with phosphatebuffered saline and incubated on ice for 15 min in CHAPS buffer. Cells were microcentrifuged, and supernatants were saved and frozen at À801C. Protein concentration of each sample was determined by Lowry assay. The enriched mitochondria pellet and mitochondria-free cytosol of KCs were prepared with the Apo Alert cell fraction kit (Clontech Laboratories, Inc., Palo Alto, CA, USA) according to the manufacturer's instructions.
In total, 30 mg of protein were loaded on 8-12.5% SDSpolyacrylamide gel, transferred onto Immobilon-p (polyvinylidene diflouride) membrane and blocked in 5% nonfat powdered milk in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 0.01% Tween 20). The membrane was incubated with the primary antibody in 2.5% powdered milk in TBST and was washed extensively with TBST and then incubated with 1 : 1500 diluted anti-rabbit or mouse horseradish peroxidase (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Proteins were visualized with ECL reagents (Amersham Pharmacia Biotech) according to the manufacturer's instruction. Loading of proteins to verify equivalent distribution of proteins in each well was confirmed by Ponceau S staining and actin levels. Differences in protein expression were determined by densitometry analysis using Scion Image software (Scion Corporation, Frederick, MD, USA).
Bax cross-linking
KCs were washed with PBS and cells were pelleted in PBS. Crosslinking was carried out as previously described by us and others (Mikhailov et al., 2003) in PBS with 0.5% of formaldehyde for 30 min at room temperature. Cells were quenched with 2% glycine solution for 15 min, cells were pelleted and resuspended in buffer A (10 mM HEPESNaOH pH 7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA and protease inhibitors). To separate cytosol from heavy fraction, the centrifugation was carried out at 15 000 for 10 min at 41C and extracted with 2% CHAPS in buffer A.
Ribonuclease protection assay
KCs were treated with control siRNA and p53 siRNA for 3 days. A dose of 30 mJ/cm 2 UVB for 3 and 6 h was used. Total cellular RNA was extracted using Trizol Reagent (Life Technologies, Inc., Grand Island, NY, USA). The RNase protection assay was performed according to the supplier's instructions (Pharmigen, San Diego, CA, USA). Briefly, human apoptosis template set human stress-2 was labeled with a 32 P uridine triphosphate. RNA (10-20 mg) and 8 Â 10 5 cpm of labeled probes were used for hybridization and after RNase treatment; the protected probes were resolved on 5% urea-polyacrylamide gels.
p53 þ /À transgenic mice Wild-type (C57BL/6J) and p53 þ /À 129 Â C57BL/6 (B6.129S2-Trp53tm1Tyi/J). male mice (Jackson Laboratory) were used at age 7 weeks. Animals were in resting phase of the hair cycle, indicated by pink skin after shaving and no measurable hair regrowth the next day. Mice were shaved on the back with clippers and electric shaver under isoflurane anesthesia. After 1 day, mice were exposed to 0 or 1000 J/m 2 UVB from three broadband FS20T12-UVB lamps filtered through a Kodacel filter (Eastman Kodak, Rochester, NY, USA) to remove wavelengths below 290 nm. Lamp output was 250-420 nm, with peak emission at 313 nm, and after filtering contained 72.6% UVB, 27.4% UVA, and 0.01% UVC, as measured by an IL1700/790 spectroradiometer with double monochromator (International Light, Inc., Newburyport, MA, USA). Dose rate was 2.2 J/m 2 /s. During irradiation, animals moved freely but were prevented from standing by a 1 cm Â 1 cm wire mesh. Mice were killed 6 h later by cervical dislocation after isoflurane anesthesia. The central portion of the dorsal skin was removed, washed with PBS, and fixed with 10% neutral formalin in PBS overnight. The animal protocol was reviewed and approved by the Yale Institutional Animal Care and Use Committee.
